Instil Bio, Inc.
Instil Bio, Inc. (TIL): 4 pipeline candidates · ~135 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
134.8 months
D/E 0.81 · 0% dilution
Lead: Phase 1
4 candidates
N/A
N/A
A transparent, data-derived signal for Instil Bio, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$51.3M
Cash
$5.1M
Quarterly Burn
$1.3M
Runway
134.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| axn-2510 | Phase 1 |
| axn-2510/imm2510 | Phase 1 |
| axn-27m/imm27m | Phase 1 |
| itil-306 | Phase 1 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
28
Total value held
$11.0M
| Holder | Shares | Value |
|---|---|---|
| cpmg inc | 410,922 | $3.4M |
| vanguard capital management llc | 349,166 | $2.9M |
| millennium management llc | 132,946 | $1.1M |
| renaissance technologies llc | 59,100 | $487K |
| blackrock, inc. | 52,018 | $429K |
| nomura asset management international inc. | 50,000 | $412K |
| geode capital management, llc | 49,011 | $404K |
| citadel advisors llc | 38,562 | $318K |
| lpl financial llc | 32,063 | $264K |
| xtx topco ltd | 26,242 | $216K |
Showing top 10 of 28 institutional holders of Instil Bio, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Instil Bio, Inc.'s pipeline?
Instil Bio, Inc. (TIL) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Instil Bio, Inc.'s lead drug candidate?
Instil Bio, Inc.'s most advanced tracked candidate is axn-2510 (Phase 1) for Solid Tumor, Adult.
What is Instil Bio, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Instil Bio, Inc. has approximately 134.8 months of cash runway.
What is Instil Bio, Inc.'s market capitalization?
Instil Bio, Inc.'s market capitalization is approximately $51.3M.
Who is the CEO of Instil Bio, Inc.?
Mr. Bronson Crouch is the chief executive officer of Instil Bio, Inc. (TIL).
Get the full picture on Instil Bio, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.